The global mineral supplements market size is estimated at USD 18.58 billion in 2025 and is predicted to reach around USD 31.20 billion by 2034, accelerating at a CAGR of 5.93% from 2025 to 2034. The Asia Pacific mineral supplements market size surpassed USD 7.43 billion in 2025 and is expanding at a CAGR of 5.94% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Mineral Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Mineral Supplements Market Revenue and Volume, by Product
8.1.1. Calcium
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Magnesium
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Iron
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Potassium
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Zinc
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Chromium
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Selenium
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Others
8.1.8.1. Market Revenue and Volume Forecast
9.1. Mineral Supplements Market Revenue and Volume, by Formulation
9.1.1. Capsule
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Dessert
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Powder
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Liquid/Gel
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast
10.1. Mineral Supplements Market Revenue and Volume, by Application
10.1.1. General Health
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Bone & Joint Health
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Gastrointestinal Health
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Immunity
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast
11.1. Mineral Supplements Market Revenue and Volume, by End-Use
11.1.1. Adults
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Geriatric
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Pregnant Women
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Children
11.1.4.1. Market Revenue and Volume Forecast
11.1.5. Infants
11.1.5.1. Market Revenue and Volume Forecast
12.1. Mineral Supplements Market Revenue and Volume, by Sales Channel
12.1.1. Pharmacies & Drug Stores
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Supermarkets & Hypermarkets
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Online Channels
12.1.3.1. Market Revenue and Volume Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product
13.1.2. Market Revenue and Volume Forecast, by Formulation
13.1.3. Market Revenue and Volume Forecast, by Application
13.1.4. Market Revenue and Volume Forecast, by End-Use
13.1.5. Market Revenue and Volume Forecast, by Sales Channel
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product
13.1.6.2. Market Revenue and Volume Forecast, by Formulation
13.1.6.3. Market Revenue and Volume Forecast, by Application
13.1.6.4. Market Revenue and Volume Forecast, by End-Use
13.1.6.5. Market Revenue and Volume Forecast, by Sales Channel
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product
13.1.7.2. Market Revenue and Volume Forecast, by Formulation
13.1.7.3. Market Revenue and Volume Forecast, by Application
13.1.7.4. Market Revenue and Volume Forecast, by End-Use
13.1.7.5. Market Revenue and Volume Forecast, by Sales Channel
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product
13.2.2. Market Revenue and Volume Forecast, by Formulation
13.2.3. Market Revenue and Volume Forecast, by Application
13.2.4. Market Revenue and Volume Forecast, by End-Use
13.2.5. Market Revenue and Volume Forecast, by Sales Channel
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product
13.2.6.2. Market Revenue and Volume Forecast, by Formulation
13.2.6.3. Market Revenue and Volume Forecast, by Application
13.2.7. Market Revenue and Volume Forecast, by End-Use
13.2.8. Market Revenue and Volume Forecast, by Sales Channel
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product
13.2.9.2. Market Revenue and Volume Forecast, by Formulation
13.2.9.3. Market Revenue and Volume Forecast, by Application
13.2.10. Market Revenue and Volume Forecast, by End-Use
13.2.11. Market Revenue and Volume Forecast, by Sales Channel
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product
13.2.12.2. Market Revenue and Volume Forecast, by Formulation
13.2.12.3. Market Revenue and Volume Forecast, by Application
13.2.12.4. Market Revenue and Volume Forecast, by End-Use
13.2.13. Market Revenue and Volume Forecast, by Sales Channel
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product
13.2.14.2. Market Revenue and Volume Forecast, by Formulation
13.2.14.3. Market Revenue and Volume Forecast, by Application
13.2.14.4. Market Revenue and Volume Forecast, by End-Use
13.2.15. Market Revenue and Volume Forecast, by Sales Channel
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product
13.3.2. Market Revenue and Volume Forecast, by Formulation
13.3.3. Market Revenue and Volume Forecast, by Application
13.3.4. Market Revenue and Volume Forecast, by End-Use
13.3.5. Market Revenue and Volume Forecast, by Sales Channel
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product
13.3.6.2. Market Revenue and Volume Forecast, by Formulation
13.3.6.3. Market Revenue and Volume Forecast, by Application
13.3.6.4. Market Revenue and Volume Forecast, by End-Use
13.3.7. Market Revenue and Volume Forecast, by Sales Channel
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product
13.3.8.2. Market Revenue and Volume Forecast, by Formulation
13.3.8.3. Market Revenue and Volume Forecast, by Application
13.3.8.4. Market Revenue and Volume Forecast, by End-Use
13.3.9. Market Revenue and Volume Forecast, by Sales Channel
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product
13.3.10.2. Market Revenue and Volume Forecast, by Formulation
13.3.10.3. Market Revenue and Volume Forecast, by Application
13.3.10.4. Market Revenue and Volume Forecast, by End-Use
13.3.10.5. Market Revenue and Volume Forecast, by Sales Channel
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product
13.3.11.2. Market Revenue and Volume Forecast, by Formulation
13.3.11.3. Market Revenue and Volume Forecast, by Application
13.3.11.4. Market Revenue and Volume Forecast, by End-Use
13.3.11.5. Market Revenue and Volume Forecast, by Sales Channel
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product
13.4.2. Market Revenue and Volume Forecast, by Formulation
13.4.3. Market Revenue and Volume Forecast, by Application
13.4.4. Market Revenue and Volume Forecast, by End-Use
13.4.5. Market Revenue and Volume Forecast, by Sales Channel
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product
13.4.6.2. Market Revenue and Volume Forecast, by Formulation
13.4.6.3. Market Revenue and Volume Forecast, by Application
13.4.6.4. Market Revenue and Volume Forecast, by End-Use
13.4.7. Market Revenue and Volume Forecast, by Sales Channel
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product
13.4.8.2. Market Revenue and Volume Forecast, by Formulation
13.4.8.3. Market Revenue and Volume Forecast, by Application
13.4.8.4. Market Revenue and Volume Forecast, by End-Use
13.4.9. Market Revenue and Volume Forecast, by Sales Channel
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product
13.4.10.2. Market Revenue and Volume Forecast, by Formulation
13.4.10.3. Market Revenue and Volume Forecast, by Application
13.4.10.4. Market Revenue and Volume Forecast, by End-Use
13.4.10.5. Market Revenue and Volume Forecast, by Sales Channel
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product
13.4.11.2. Market Revenue and Volume Forecast, by Formulation
13.4.11.3. Market Revenue and Volume Forecast, by Application
13.4.11.4. Market Revenue and Volume Forecast, by End-Use
13.4.11.5. Market Revenue and Volume Forecast, by Sales Channel
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product
13.5.2. Market Revenue and Volume Forecast, by Formulation
13.5.3. Market Revenue and Volume Forecast, by Application
13.5.4. Market Revenue and Volume Forecast, by End-Use
13.5.5. Market Revenue and Volume Forecast, by Sales Channel
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product
13.5.6.2. Market Revenue and Volume Forecast, by Formulation
13.5.6.3. Market Revenue and Volume Forecast, by Application
13.5.6.4. Market Revenue and Volume Forecast, by End-Use
13.5.7. Market Revenue and Volume Forecast, by Sales Channel
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product
13.5.8.2. Market Revenue and Volume Forecast, by Formulation
13.5.8.3. Market Revenue and Volume Forecast, by Application
13.5.8.4. Market Revenue and Volume Forecast, by End-Use
13.5.8.5. Market Revenue and Volume Forecast, by Sales Channel
14.1. Glanbia, plc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Nestle
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Biovea
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Herbalife International of America, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Sanofi
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Amway
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Bayer AG
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Omega Protein Corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Bio Botanica, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client